Survival following the documentation of platinum and taxane resistance in ovarian cancer

Gynecol Oncol. 2004 Dec;95(3):774-5; author reply 775-6. doi: 10.1016/j.ygyno.2004.08.013.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Bridged-Ring Compounds / therapeutic use*
  • Drug Resistance, Multiple*
  • Drug Resistance, Neoplasm
  • Female
  • Humans
  • Organoplatinum Compounds / therapeutic use*
  • Ovarian Neoplasms / drug therapy*
  • Taxoids / therapeutic use*

Substances

  • Antineoplastic Agents
  • Bridged-Ring Compounds
  • Organoplatinum Compounds
  • Taxoids
  • taxane